Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pain

Do ACE inhibitors exacerbate complex regional pain syndrome?

Complex regional pain syndrome is a chronic condition arising mainly after tissue injury and involves both inflammatory and neurogenic factors. Use of angiotensin-converting-enzyme inhibitors has been associated with an increased risk of developing the chronic pain condition, which suggests possible roles for substance P and bradykinin in the underlying pathogenic process.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. de Mos, M., Huygen, F. J., Stricker, B. H., Dieleman, J. P. & Sturkenboom, M. C. The association between ACE inhibitors and the complex regional pain syndrome: suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain 142, 218–224 (2009).

    Article  CAS  Google Scholar 

  2. Jänig, W. & Baron, R. Complex regional pain syndrome is a disease of the central nervous system. Clin. Auton. Res. 12, 150–164 (2002).

    Article  Google Scholar 

  3. Leeb-Lundberg, L. M., Marceau, F., Müller-Esterl, W., Pettibone, D. J. & Zuraw, B. L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27–77 (2005).

    Article  CAS  Google Scholar 

  4. Kopp, U. C., Cicha, M. Z. & Smith, L. A. Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP. Am. J. Physiol. 285, 472–483 (2003).

    Google Scholar 

  5. Parpura, V. et al. Glutamate-mediated astrocyte-neuron signalling. Nature 369, 744–747 (1994).

    Article  CAS  Google Scholar 

  6. Fusayasu, E., Kowa, H., Takeshima, T., Nakaso K. & Nakashima, K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128, 209–214 (2007).

    Article  CAS  Google Scholar 

  7. Suzuki, R., Morcuende, S., Webber, M., Hunt, S. P. & Dickenson, A. H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat. Neurosci. 5, 1319–1326 (2002).

    Article  CAS  Google Scholar 

  8. Budai, D., Khasabov, S. G., Mantyh, P. W. & Simone, D. A. NK-1 receptors modulate the excitability of ON cells in the rostral ventromedial medulla. J. Neurophysiol. 97, 1388–1395 (2007).

    Article  CAS  Google Scholar 

  9. McMahon, S. B., Cafferty, W. B. & Marchand, F. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444–462 (2005).

    Article  CAS  Google Scholar 

  10. Hay, J. L. et al. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J. Pain 10, 316–322 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Borsook.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borsook, D., Sava, S. Do ACE inhibitors exacerbate complex regional pain syndrome?. Nat Rev Neurol 5, 306–308 (2009). https://doi.org/10.1038/nrneurol.2009.73

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2009.73

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing